Key facts
- It has raised $1.2M; the latest was Later Stage VC ($1.2M) in Jul 2025.
- Notable investors include AiZei, Moonstone Fund.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Cultipharm
- ·The full record, as it builds
Funding rounds
No funding rounds for Cultipharm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cultipharm
Manufacturer of botanicals and active ingredients intended for the pharmaceutical, nutraceutical, and cosmetic sectors. The company cultivates plants in stacked layers, creating a controlled and soilless environment where each plant is positioned in overlapping cultivation planes that can be moved automatically, enabling pharmaceutical, nutraceutical, and cosmetic industries to embrace the power of vertical farming.
- Sector
- Materials and Resources
- HQ
- Mantua, Italy
- Founded
- 2020
- Employees
- 5
- Website
- cultipharm.it/
- Ownership
- Privately Held (backing)
Cultipharm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cultipharm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cultipharm in its N-PORT filings yet. We sweep new filings monthly.